First Tracks: Huge Cash Reserves Will Not Sustain Testing For Long
First Tracks Biotherapeutics, spun off from AnaptysBio, launches with $180M cash and a diverse, earl…

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
1 signal unavailable — limited data for this stock
Trend
+18.3% vs SMA 50 · +23.3% vs SMA 200
Momentum
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $2.4B $2.3B–$2.5B | — | $0.29 | — | ±21% | High9 |
FY2026(current) | $2.3B $2.3B–$2.3B | ▼ -4.2% | $0.10 | ▼ -67.2% | ±50% | Moderate4 |
FY2027 | $2.3B $2.3B–$2.4B | ▲ +0.8% | $1.04 | ▲ +987.9% | ±50% | Moderate4 |
First Tracks Biotherapeutics, spun off from AnaptysBio, launches with $180M cash and a diverse, earl…

iac is a leading media and internet company comprised of more than 150 brands and products, including ask.com, about.com, match.com, homeadvisor and vimeo. focused on the areas of search, applications, online dating, media and ecommerce, iac's family of websites is one of the largest in the world, with over two billion monthly visits reaching users in more than 200 countries. the company is headquartered in new york city and has offices worldwide. to view a full list of the companies of iac, please visit our website at www.iac.com.